Patent ID: 9110079
Filing Date: 2015-08-18
Classification: C12Q,G01N

Abstract:
1. An in vitro method of providing a survival prognosis for a patient having SIRS, the method comprising: measuring expression levels of a combination of target genes from biological material of a sample obtained from the patient using reagents specific for the respective target gene products that are selected from the group consisting of probes, primers, antibodies, and antibody fragments; comparing the expression levels to one or more predetermined thresholds indicative of a survival prognosis for the patient; and providing a survival prognosis for the patient so that care for the patient is able to be determined in accordance with the survival prognosis, wherein the combination of target genes includes at least one CX3CR1 gene and at least one other target gene selected from the group consisting of S100A8, S100A9, IL-10, TNFA, HLA-DR, CIITA, and IRAK3.